A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/2007
10/18/2007	US20070243570 Apoptosis Inducer for Cancer Cell
10/18/2007	US20070243547 Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker
10/18/2007	US20070243226 Growth factor complex
10/18/2007	US20070243201 Method for Selecting Epitopes for Immunotherapy
10/18/2007	US20070243192 Growth hormone receptor antagonist cancer treatment
10/18/2007	US20070243191 Anti-hyperproliferative therapies targeting hdgf
10/18/2007	US20070243185 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine.
10/18/2007	US20070243176 Human genes and gene expression products
10/18/2007	US20070243175 Methods and compositions for regenerating tissue
10/18/2007	US20070243174 Methods and compositions for directing stem cells to the liver
10/18/2007	US20070243173 Methods and compositions for directing stem cells to the heart
10/18/2007	US20070243162 Labeled monoclonal antibody binds Kaposi's sarcoma-associated herpesvirus (KSHV); use in diagnosis and prognosis
10/18/2007	US20070243161 Epigenetic modification of the loci for CAMTA1 and/or FOXP3 as a marker for cancer treatment
10/18/2007	DE102006017831A1 Producing transgenic brassica plants with increased glucosinolate synthesis comprises causing overexpression of the gene coding for transcription factor MYB51
10/18/2007	CA2659767A1 Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same
10/18/2007	CA2651911A1 Anti ku70 internalizing antibodies
10/18/2007	CA2651898A1 Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
10/18/2007	CA2649182A1 Methods and compositions related to adenoassociated virus-phage particles
10/18/2007	CA2649000A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases
10/18/2007	CA2648923A1 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
10/18/2007	CA2648846A1 Antibody compositions and methods for treatment of neoplastic disease
10/18/2007	CA2648324A1 2-methylene-1.alpha.,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof
10/18/2007	CA2648193A1 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
10/18/2007	CA2647803A1 Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor
10/18/2007	CA2647690A1 Novel cyclobutyl compounds as kinase inhibitors
10/18/2007	CA2647502A1 Onco-tool compositions and methods of use for detecting and treating tumors
10/18/2007	CA2647292A1 Thiazolyldihydrocyclopentapyrazoles for use as pi3-kinase inhibitors
10/18/2007	CA2647288A1 Glycosylated antibodies
10/18/2007	CA2644951A1 Chromen-2-one derivatives
10/18/2007	CA2644841A1 Use of c-src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia
10/17/2007	EP1845106A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
10/17/2007	EP1845102A1 Novel pyrimidine nucleoside compound or its salt
10/17/2007	EP1845096A1 12-Aza-epothilones, process for their preparation and their use as antiproliferative agents
10/17/2007	EP1845094A1 Method of tumor suppression and evaluation of anticancer agent based on gsk3 beta inhibitory effect
10/17/2007	EP1844815A1 Combination therapy comprising anti-CD20 and anti-CD40 antibodies for the treatment of B cell-related cancers
10/17/2007	EP1844794A1 Silicon implants comprising a radionucleotide and/or a cytotoxic drug and their use in cancer treatment
10/17/2007	EP1844788A1 HER-2/neu multi-peptide vaccine
10/17/2007	EP1844772A1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
10/17/2007	EP1844767A2 Epoxide hydrolase complexes and methods therewith
10/17/2007	EP1844766A2 Inhibitors against the production and release of inflammatory cytokines
10/17/2007	EP1844336A1 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
10/17/2007	EP1844201A2 Aqueous gel formulations containing immune response modifiers
10/17/2007	EP1844077A2 Dr5 antibodies and uses thereof
10/17/2007	EP1844068A1 Molecules and chimeric molecules thereof
10/17/2007	EP1844067A2 Novel peptides which interact with anti-apoptotic members of the family of bcl-2 proteins and use thereof
10/17/2007	EP1844066A1 Motif of beclin protein which interacts with anti-apoptotic members of the family of bcl-2 proteins and use thereof
10/17/2007	EP1844062A2 Inhibitors of dna methyltransferase
10/17/2007	EP1844048A1 Pyrazolopyrimidines as cell cycle kinase inhibitors
10/17/2007	EP1844046A1 Novel indolopyridines, benzofuranopyridines and benzothienopyridines
10/17/2007	EP1844027A1 Thiazolidinones for use as inhibitors of polo-like kinase (plk)
10/17/2007	EP1844020A1 Heterocyclic carboxamide compounds as steroid nuclear receptor ligands
10/17/2007	EP1843784A2 Identification of phospholipase a2 as target in cancer treatment, with special emphasis on colorectal cancer and its mechanism of action
10/17/2007	EP1843773A1 Method and composition for treatment of neoplasms
10/17/2007	EP1843760A1 Classes of compounds that interact with integrins
10/17/2007	EP1843759A1 Therapeutic compounds isolated form calomeria amarnthoides
10/17/2007	EP1843758A1 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
10/17/2007	EP1565438B1 Antitumor benzoylsulfonamides
10/17/2007	EP1482911B1 Water dispersible mixture comprising complex carbohydrates from aloe vera and polyvinylpyrrolidone
10/17/2007	EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007	EP1303291B1 Anti-hiv and anti-tumor peptides and fragments of lysozyme
10/17/2007	EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
10/17/2007	EP1276770B1 Proteins with a high immunoreactivity and a method for the production thereof
10/17/2007	EP1267848B1 Dosing regimen comprising a farnesyl protein transferase inhibitor for the treatment of cancer
10/17/2007	EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
10/17/2007	EP1141728B1 Kidney disease detection and treatment
10/17/2007	EP1123387B1 Mn gene and protein
10/17/2007	EP1102758B1 Particle-forming compositions containing fused pyrrolocarbazoles
10/17/2007	EP0993613B8 Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumours originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma
10/17/2007	EP0787122B9 Calcium receptor-active compounds
10/17/2007	CN101056871A Novel anthranilamide pyridinureas as vegf receptor kinase inhibitors
10/17/2007	CN101056868A Substituted chroman derivatives, medicaments and use in therapy
10/17/2007	CN101056619A Pharmaceutical compositions comprising a camtothecin derivate
10/17/2007	CN101054604A Application of oligonucleotide complemented with rna used as transcription product of gene
10/17/2007	CN101054596A Recombination adenovirus for curing overexpression proto-oncogene neu/erbB2 malignancy
10/17/2007	CN101054591A Oligonucleotide for targeted activation of chronic granulocyte leukaemia protein kinase PKR and application thereof
10/17/2007	CN101054578A Hairpin RNA and application thereof
10/17/2007	CN101054577A A siRNA and expression carrier capable of inhibiting Bax gene expression and application of the same used as virus hepatitis B treatment medicament
10/17/2007	CN101054419A Vectors with modified protease-dependent tropism
10/17/2007	CN101054417A Recombinant antibodies related to ganglioside and its application in diagnosing and treating tumor
10/17/2007	CN101054413A Tumor correlated albumen, coding gene and application thereof
10/17/2007	CN101054403A Novel antibiotic Chemomycin A, B, C, D and preparation method thereof
10/17/2007	CN101054400A Novel Panoxadiol and derivative, preparation method and medical use thereof
10/17/2007	CN101054394A Nitryl aromatic imine substituted hexamolybdic acid tetrabutylamine derivative and preparation method and application thereof
10/17/2007	CN101054383A Bromodihydroartemisinin and preparation method thereof
10/17/2007	CN101054382A Gamboges acid derivative, process for producing the same, and use thereof
10/17/2007	CN101054380A Pyrazolopyrimidine derivative used as cell cycle dependency protein kinase inhibito
10/17/2007	CN101054367A 3-Amino-1,2,4-phentriazine-1,4-dinitrogen oxide dihydrate, its preparation method and application in tumour radiotherapy and chemotherapy
10/17/2007	CN101054344A Lipoxin A4 analogs
10/17/2007	CN101053664A Construction and expression for tumor immunity synergistic carrier pBVIM
10/17/2007	CN101053663A Replication competent type DNA vaccine carrier pSFVax1-IRES and its construction method
10/17/2007	CN101053645A Yellow plaster for treating tumor and preparation method
10/17/2007	CN101053587A Medicinal composition for treating tumor and preparation method and quality control method thereof
10/17/2007	CN101053575A Application of chitoser ester in preparing anti-tumor medicine
10/17/2007	CN101053574A Medicinal composition containing chitoser ester and preparation method and application thereof
10/17/2007	CN101053573A Compositions and methods based on VEGF antisense oligonucleotides
10/17/2007	CN101053561A Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis
10/17/2007	CN101053553A Biodegradable fluorourcacil polyester medicine-carried nanospheres and its preparation method
10/17/2007	CN101053551A Carried nitrosoureas drug and alkylating agent for anti-cancer composition
10/17/2007	CN101053438A Health care beverage
10/17/2007	CN101053437A Organic germanium Ge-132 glossy ganoderma beverage and processing method

1 ... 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 ... 2211